Effects of a single low dose of ranitidine and effervescent antacids on intragastric acidity in healthy volunteers

Acta Gastroenterologica Latinoamericana

Volumn 37, Issue 4, 2007, Pages 231-237

  Améndola, Rafael ^a   De Los Santos, María Cecilia ^b   Massa, Javier Martinelli ^b   Vazquez, Horacio ^a   Smecuol, Edgardo ^a  

^a Investigación Gastroenterológica Asociación Civil   (Argentina)

^b Glaxo Smith Kline Argentina

Author keywords

Antacids; Gastric acidity; Ranitidine

Indexed keywords

ANTACID AGENT; ANTIULCER AGENT; RANITIDINE;

ADULT; ARTICLE; DIET RESTRICTION; FEMALE; HUMAN; MALE; MIDDLE AGED; PH; SECRETION; STOMACH ACID; STOMACH PH; TIME;

ADULT; ANTACIDS; ANTI-ULCER AGENTS; FASTING; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; RANITIDINE; TIME FACTORS;

EID: 37549062679     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesopHageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
2. Katz PO, Castell DO. Treatment of mild to moderate gastroeso pHageal reflux disease. Practical Gastroenterology 1997:46-53.
3. Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of aluminum/magnesium hydroxide and calcium carbonate on esophageal and gastric pH in subjects with heartburn. Am J Ther 1995;2:546-552.
4. 2-receptor antagonists (ranitidine, famotidine) on intragastric acidity. Aliment Pharmacol Ther 1998;12:337-342.
5. Ciociola AA, Pappa KA, Sirgo MA. Nonprescription doses of ranitidine are effective in the relief of episodic heartburn. Am J Ther 2001;8:399-408.
6. Galmiche JP, Shi G, Simon B, Casset-Semanza F, Slama A. On-demand treatment of gastro-oesopHageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo. Aliment Pharmacol Ther 1998;12:909-917.
7. Pappa KA, Williams BO, Payne JE, Buaron KS, Mussari KL, Ciociola AA. A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn. Aliment Pharmacol Ther 1999;13:467-473.
8. Pehl C, Boccali I, Hennig M, Schepp W. pH probe positioning for 24-hour pH-metry by manometry or pH step-up. Eur J Gastroenterol Hepatol 2004;16:375-382.
9. th World Medical Assembly, Somerset West, Republic of South Africa, October 1996.
10. th July 1996.
11. Sontag S, Robinson M Mc Callum RW, et al. Ranitidine therapy for gastroesopHageal reflux disease. Results of a large double-blind trial. Arch Intern Med 1987;147:1485-1491.
12. Committee on the Safety of Medicines. Medicines newly released for self-medication. Curr Probl Pharmacovigil (MCA) 1994;20:4.
13. Sontag SJ. The medical management of reflux esopHagitis. Role of antacids and acid inhibition. Gastroenterol Clin North Am 1990;19:683-712.
14. Feldman y Blackwell JN, Wu CS, Castell DO: Clinical applications of oesopHageal motility studies. Br J Hosp Med 1984;32:267-271.
15. Labenz J, Peitz U, Leusing C y col. Efficay of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study Gut 1997;40: 36-41.
16. Hellke P, Elm M. Comparison of Zantac standard tablets (ST) with Zantac effervescent tablets (ET) in the relief of symptoms of gastro-oesopHageal reflux disease after single-dose intake. Scand J Gastroenterol 1996;31(Suppl 217): S44.
17. Engzelius JM, Solhaug JH, Knapstad LJ y col. Ranitidine effervescent tablets vs. Famotidine wafer in the relief of episodic symptoms of GORD. Scand J Gastroenterol 1996;31 (Suppl 217):S44.
18. 2-eceptor antagonist in the treatment of gastro-oesopHageal reflux disease. Aliment Pharmacol Ther 1995;9 (Suppl 1):S9-S14.
19. Smith JL, Operkun AR, Larkai E, Graham DY. Sensitivity of the esopHageal mucosa to pH in gastroesopHageal reflux disease. Gastroenterology 1989;96:683-689.
20. Bell NJ, Burget D, Howden CW y col. Appropriate acid suppression for the management of gastrooesopHageal disease. Digestion 1992:51 (Suppl 1):S59-S67.
21. Grimley CE, Constantinides S, Snell CC. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo Aliment Pharmacol Ther. 1997;11:875-879.
22. Mills JG, Koch KM, Webster C, et al. The safety of ranitidine in over a decade of use. Aliment Pharmacol Ther 1997;11:129-137.